CDRH Promotes Bayesian Tool To Speed Approvals; Statistical Rigor Required

FDA is encouraging medical device firms to consider using Bayesian estimation in clinical trials to streamline regulatory timeframes

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight

Tariffs In Focus: Projections From 4 Medtech Giants (Q1 Vs Q2)

 

Roche Diagnostics, Intuitive Surgical, Abbott and Edwards Lifesciences all acknowledge tariff headwinds, but stress preparedness, resilience and mitigation. Below is look at how management framed the impact in Q1 vs Q2 earnings calls.

Medtech Must Address AI Risks Now Or Jeopardize Its Future Potential, Expert Warns

 

Urgent action is needed to address gaps in how risks from medical devices and diagnostics utilizing AI are identified, mitigated and managed. So says James Pink, renowned medtech regulatory expert in an interview with Medtech Insight.

Exercise Caution While Using Hyperbaric Oxygen Therapy Devices, FDA Warns

 

The US FDA has published a list of recommendations for the safe use of hyperbaric oxygen therapy devices. While the therapy can be effective in treating several conditions, the agency says providers need to understand its potential risks.